BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11498756)

  • 1. Unrelated cord blood transplantation in a Fanconi anemia patient using fludarabine-based conditioning.
    de Medeiros CR; Silva LM; Pasquini R
    Bone Marrow Transplant; 2001 Jul; 28(1):110-2. PubMed ID: 11498756
    [No Abstract]   [Full Text] [Related]  

  • 2. Allogeneic haematopoietic cell transplantation from alternative donors with a conditioning regimen of low-dose irradiation, fludarabine and cyclophosphamide in Fanconi anaemia.
    Yabe H; Inoue H; Matsumoto M; Hamanoue S; Koike T; Ishiguro H; Koike H; Suzuki K; Kato S; Kojima S; Tsuchida M; Mori T; Adachi S; Tsuji K; Koike K; Morimoto A; Sako M; Yabe M
    Br J Haematol; 2006 Jul; 134(2):208-12. PubMed ID: 16846479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-TBI stem cell transplantation protocol for Fanconi anaemia using HLA-compatible sibling and unrelated donors.
    de la Fuente J; Reiss S; McCloy M; Vulliamy T; Roberts IA; Rahemtulla A; Dokal I
    Bone Marrow Transplant; 2003 Oct; 32(7):653-6. PubMed ID: 13130311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fludarabine-based cytoreductive regimen and T-cell-depleted grafts from alternative donors for the treatment of high-risk patients with Fanconi anaemia.
    Chaudhury S; Auerbach AD; Kernan NA; Small TN; Prockop SE; Scaradavou A; Heller G; Wolden S; O'Reilly RJ; Boulad F
    Br J Haematol; 2008 Mar; 140(6):644-55. PubMed ID: 18302713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful engraftment without radiation after fludarabine-based regimen in Fanconi anemia patients undergoing genotypically identical donor hematopoietic cell transplantation.
    Tan PL; Wagner JE; Auerbach AD; Defor TE; Slungaard A; Macmillan ML
    Pediatr Blood Cancer; 2006 May; 46(5):630-6. PubMed ID: 16078221
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-radiotherapy conditioning with stem cell transplantation from alternative donors in children with refractory severe aplastic anemia.
    Urban C; Benesch M; Sykora KW; Schwinger W; Lackner H
    Bone Marrow Transplant; 2005 Mar; 35(6):591-4. PubMed ID: 15665850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful T-cell-depleted, related haploidentical peripheral blood stem cell transplantation in a patient with Fanconi anaemia using a fludarabine-based preparative regimen without radiation.
    Rossi G; Giorgiani G; Comoli P; Nobili B; Salvaneschi L; De Stefano P; Maccario R; Locatelli F
    Bone Marrow Transplant; 2003 Mar; 31(6):437-40. PubMed ID: 12665837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation of patients with FA and high risk features using fludarabine without radiation.
    Baker JM; Lewis VA; Fernandez CV; Duval M; Crooks BN; Yuille K; Freedman MH; Doyle JJ; Dror Y
    Pediatr Blood Cancer; 2009 May; 52(5):683-5. PubMed ID: 19156855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Allogeneic blood stem cell transplantation in high-risk patients after conditioning with treosulfan and fludarabine].
    Casper J; Wilhelm S; Steiner B; Wolff D; Grobe N; Hähling D; Hartung G; Hilgendorf I; Lück A; Junghanss C; Kahl C; Baumgart J; Pichlmeier U; Freund M
    Dtsch Med Wochenschr; 2005 Sep; 130(38):2125-9. PubMed ID: 16172951
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results of unrelated cord blood transplant in fanconi anemia patients: risk factor analysis for engraftment and survival.
    Gluckman E; Rocha V; Ionescu I; Bierings M; Harris RE; Wagner J; Kurtzberg J; Champagne MA; Bonfim C; Bittencourt M; Darbyshire P; Fernandez MN; Locatelli F; Pasquini R;
    Biol Blood Marrow Transplant; 2007 Sep; 13(9):1073-82. PubMed ID: 17697970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prompt and durable hematopoietic reconstitution by unrelated cord blood transplantation in a child with Fanconi anemia.
    Yoshimasu T; Tanaka R; Suenobu S; Yagasaki H; Yoshino H; Ueda T; Hisakawa H; Ishii T; Mitsui T; Ebihara Y; Manabe A; Iseki T; Maekawa T; Nakahata T; Asano S; Tsuji K
    Bone Marrow Transplant; 2001 Apr; 27(7):767-9. PubMed ID: 11360120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndrome.
    Kröger N; Schetelig J; Zabelina T; Krüger W; Renges H; Stute N; Schrum J; Kabisch H; Siegert W; Zander AR
    Bone Marrow Transplant; 2001 Oct; 28(7):643-7. PubMed ID: 11704786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The outcome of children with Fanconi anemia given hematopoietic stem cell transplantation and the influence of fludarabine in the conditioning regimen: a report from the Italian pediatric group.
    Locatelli F; Zecca M; Pession A; Morreale G; Longoni D; Di Bartolomeo P; Porta F; Fagioli F; Nobili B; Bernardo ME; Messina C;
    Haematologica; 2007 Oct; 92(10):1381-8. PubMed ID: 18024375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful allo-SCT in a Fanconi anemia patient with renal impairment using reduced doses of CY and fludarabine.
    Turkistani W; Ashour M; Al-Mojalli H; Ayas M
    Bone Marrow Transplant; 2010 Feb; 45(2):415-6. PubMed ID: 19597429
    [No Abstract]   [Full Text] [Related]  

  • 15. CD-34 selected hematopoetic stem cell transplantation from HLA identical family members for fanconi anemia.
    Balci YI; Akdemir Y; Gumruk F; Cetin M; Arpaci F; Uckan D
    Pediatr Blood Cancer; 2008 May; 50(5):1065-7. PubMed ID: 18000858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD.
    Novitzky N; Thomas V; du Toit C; McDonald A
    Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler).
    Grigull L; Beilken A; Schrappe M; Das A; Luecke T; Sander A; Stanulla M; Rehe K; Sauer M; Schmid H; Welte K; Lukacs Z; Gal A; Sykora KW
    Bone Marrow Transplant; 2005 Feb; 35(3):265-9. PubMed ID: 15580280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addition of High-Dose Cytarabine to Fludarabine-Based Conditioning for Hematopoietic Stem Cell Transplantation for Treating Fanconi Anemia Patients with Advanced Myeloid Malignancy: A Single-Center Experience and Literature Review.
    Aoki T; Koh K; Ikeda Y; Sekinaka Y; Akiyama K; Mori M; Arakawa Y; Hanada R
    Biol Blood Marrow Transplant; 2016 Sep; 22(9):1725-1728. PubMed ID: 27246371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced intensity conditioning using intravenous busulfan, fludarabine and rabbit ATG for children with nonmalignant disorders and CML.
    Horn B; Baxter-Lowe LA; Englert L; McMillan A; Quinn M; Desantes K; Cowan M
    Bone Marrow Transplant; 2006 Feb; 37(3):263-9. PubMed ID: 16327813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation using a reduced-intensity conditioning regimen in infants: experience at a single institution in Mexico.
    Llano OG; Perez JC; Rodriguez OC; Guerra CM; Aguirre HG; Garza JL; Rodriguez-Romo L; Almaguer DG
    Pediatr Hematol Oncol; 2008; 25(1):39-47. PubMed ID: 18231953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.